Literature DB >> 24642471

IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.

Matjaz Rokavec, Meryem Gülfem Öner, Huihui Li, Rene Jackstadt, Longchang Jiang, Dmitri Lodygin, Markus Kaller, David Horst, Paul K Ziegler, Sarah Schwitalla, Julia Slotta-Huspenina, Franz G Bader, Florian R Greten, Heiko Hermeking.   

Abstract

Members of the miR-34 family are induced by the tumor suppressor p53 and are known to inhibit epithelial-to-mesenchymal transition (EMT) and therefore presumably suppress the early phases of metastasis. Here, we determined that exposure of human colorectal cancer (CRC) cells to the cytokine IL-6 activates the oncogenic STAT3 transcription factor, which directly represses the MIR34A gene via a conserved STAT3-binding site in the first intron. Repression of MIR34A was required for IL-6-induced EMT and invasion. Furthermore, we identified the IL-6 receptor (IL-6R), which mediates IL-6-dependent STAT3 activation, as a conserved, direct miR-34a target. The resulting IL-6R/STAT3/miR-34a feedback loop was present in primary colorectal tumors as well as CRC, breast, and prostate cancer cell lines and associated with a mesenchymal phenotype. An active IL-6R/STAT3/miR-34a loop was necessary for EMT, invasion, and metastasis of CRC cell lines and was associated with nodal and distant metastasis in CRC patient samples. p53 activation in CRC cells interfered with IL-6-induced invasion and migration via miR-34a-dependent downregulation of IL6R expression. In Mir34a-deficient mice, colitis-associated intestinal tumors displayed upregulation of p-STAT3, IL-6R, and SNAIL and progressed to invasive carcinomas, which was not observed in WT animals. Collectively, our data indicate that p53-dependent expression of miR-34a suppresses tumor progression by inhibiting a IL-6R/STAT3/miR-34a feedback loop.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24642471      PMCID: PMC3973098          DOI: 10.1172/JCI73531

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  65 in total

1.  Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane.

Authors:  M Takahashi; S Nakatsugi; T Sugimura; K Wakabayashi
Journal:  Carcinogenesis       Date:  2000-06       Impact factor: 4.944

2.  Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.

Authors:  Hua Xiong; Jie Hong; Wan Du; Yan-wei Lin; Lin-lin Ren; Ying-chao Wang; Wen-yu Su; Ji-lin Wang; Yun Cui; Zhen-hua Wang; Jing-Yuan Fang
Journal:  J Biol Chem       Date:  2011-12-28       Impact factor: 5.157

3.  Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation.

Authors:  S R Frank; M Schroeder; P Fernandez; S Taubert; B Amati
Journal:  Genes Dev       Date:  2001-08-15       Impact factor: 11.361

Review 4.  Roles for microRNAs in conferring robustness to biological processes.

Authors:  Margaret S Ebert; Phillip A Sharp
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

Review 5.  Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin.

Authors:  Thomas Brabletz; Falk Hlubek; Simone Spaderna; Otto Schmalhofer; Elke Hiendlmeyer; Andreas Jung; Thomas Kirchner
Journal:  Cells Tissues Organs       Date:  2005       Impact factor: 2.481

6.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

Review 7.  STATs in cancer inflammation and immunity: a leading role for STAT3.

Authors:  Hua Yu; Drew Pardoll; Richard Jove
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

8.  miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.

Authors:  Na Li; Hanjiang Fu; Yi Tie; Zheng Hu; Wei Kong; Yongge Wu; Xiaofei Zheng
Journal:  Cancer Lett       Date:  2008-11-08       Impact factor: 8.679

9.  Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors.

Authors:  Sarah Schwitalla; Paul K Ziegler; David Horst; Valentin Becker; Irina Kerle; Yvonne Begus-Nahrmann; André Lechel; K Lenhard Rudolph; Rupert Langer; Julia Slotta-Huspenina; Franz G Bader; Olivia Prazeres da Costa; Markus F Neurath; Alexander Meining; Thomas Kirchner; Florian R Greten
Journal:  Cancer Cell       Date:  2012-12-27       Impact factor: 31.743

Review 10.  The IL-6/sIL-6R complex as a novel target for therapeutic approaches.

Authors:  Stefan Rose-John; Georg H Waetzig; Jürgen Scheller; Joachim Grötzinger; Dirk Seegert
Journal:  Expert Opin Ther Targets       Date:  2007-05       Impact factor: 6.902

View more
  285 in total

Review 1.  Emerging cytokine networks in colorectal cancer.

Authors:  Nathan R West; Sarah McCuaig; Fanny Franchini; Fiona Powrie
Journal:  Nat Rev Immunol       Date:  2015-09-11       Impact factor: 53.106

2.  MicroRNA-216b is Down-Regulated in Human Gastric Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by Targeting Oncogene HDAC8.

Authors:  Ying Wang; Po Xu; Jun Yao; Ruina Yang; Zhenguo Shi; Xiaojuan Zhu; Xiaoshan Feng; Shegan Gao
Journal:  Target Oncol       Date:  2016-04       Impact factor: 4.493

3.  G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.

Authors:  Saurabh Agarwal; Anna Lakoma; Zaowen Chen; John Hicks; Leonid S Metelitsa; Eugene S Kim; Jason M Shohet
Journal:  Cancer Res       Date:  2015-04-23       Impact factor: 12.701

Review 4.  Targeting the IL-6/JAK/STAT3 signalling axis in cancer.

Authors:  Daniel E Johnson; Rachel A O'Keefe; Jennifer R Grandis
Journal:  Nat Rev Clin Oncol       Date:  2018-02-06       Impact factor: 66.675

Review 5.  Noncoding RNA and colorectal cancer: its epigenetic role.

Authors:  Yoshiaki Kita; Keiichi Yonemori; Yusaku Osako; Kenji Baba; Shinichiro Mori; Kosei Maemura; Shoji Natsugoe
Journal:  J Hum Genet       Date:  2016-06-09       Impact factor: 3.172

6.  CAPS1 promotes colorectal cancer metastasis via Snail mediated epithelial mesenchymal transformation.

Authors:  Guang-Xi Zhao; Ying-Ying Xu; Shu-Qiang Weng; Si Zhang; Ying Chen; Xi-Zhong Shen; Ling Dong; She Chen
Journal:  Oncogene       Date:  2019-02-11       Impact factor: 9.867

Review 7.  Emergence of miR-34a in radiation therapy.

Authors:  Jerome Lacombe; Frederic Zenhausern
Journal:  Crit Rev Oncol Hematol       Date:  2016-12-01       Impact factor: 6.312

8.  Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR-34a.

Authors:  Xiaojia Huang; Xinhua Xie; Peng Liu; Lu Yang; Bo Chen; Cailu Song; Hailin Tang; Xiaoming Xie
Journal:  Oncogene       Date:  2018-07-24       Impact factor: 9.867

Review 9.  The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas.

Authors:  Brian D Adams; Christine Parsons; Frank J Slack
Journal:  Expert Opin Ther Targets       Date:  2015-12-11       Impact factor: 6.902

10.  CDX2 is involved in microRNA-associated inflammatory carcinogenesis in gastric cancer.

Authors:  Motonobu Saito; Hirokazu Okayama; Katsuharu Saito; Jin Ando; Kensuke Kumamoto; Izumi Nakamura; Shinji Ohki; Yoshimasa Ishi; Seiichi Takenoshita
Journal:  Oncol Lett       Date:  2017-09-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.